I recommend choosing CCI positive control samples by matching five elements: the container closure system, the leak test method, the intended defect type, the required detection sensitivity, and the way the control will be used in your laboratory. A suitable control should contain a known and documented artificial leak or defect that represents the challenge your test method is expected to detect. It should also be stable, identifiable, repeatable, and supplied with enough technical information for your quality records. At Zholion, we help laboratories and packaging teams define these requirements before selecting or customizing positive control samples.
Please visit our website for more information on this topic.
Container closure integrity testing is used to evaluate whether a package can prevent the unwanted movement of air, gas, liquid, or microorganisms under defined conditions. A positive control sample is intentionally made or configured with a known defect so that the laboratory can confirm whether its test system responds as expected. It is not the same as a routine production sample, because its purpose is to challenge the method rather than represent normal packaging output.
The wrong control can create misleading results. For example, a control designed for a rigid vial may not behave like a flexible pouch, while a defect suitable for a pressure-decay method may not produce the same response in a vacuum-based or tracer-gas method. I therefore treat positive control selection as a method-matching exercise, not simply a product purchase.
First, I identify what the laboratory needs to prove. The objective may be method development, equipment qualification, routine system suitability, analyst training, packaging validation, or investigation of an unexpected result. Each purpose may require a different control format, quantity, level of documentation, and replacement plan.
For routine quality control, the control should be easy to identify and use consistently. For method development, the laboratory may need several defect levels or several container configurations to establish the operating range. For an investigation, the most useful control may be one that closely reproduces the suspected failure mode without changing other package characteristics.
Container geometry and material influence how a defect behaves during testing. Glass vials, polymer bottles, prefilled syringes, ampoules, blister packs, cartridges, bags, and other flexible packages can respond differently to pressure, vacuum, temperature, and mechanical handling. The control should therefore use the same or a sufficiently representative container closure configuration as the product under evaluation.
I pay particular attention to the closure interface. A defect through a stopper, seal, cap liner, weld, port, or luer connection may generate a different signal from a defect in the container wall. If the positive control does not represent the relevant closure pathway, the test may confirm instrument response without adequately challenging the actual packaging risk.
Material compatibility is also important. A liquid-filled control, for example, may interact differently with elastomers or polymer films than a dry control. If the laboratory uses a tracer gas, the control must be compatible with the selected gas and test configuration, while a dye or liquid intrusion approach may require a visually or chemically suitable internal medium.
When discussing a design with Zholion, I normally specify the container type, nominal volume, closure material, sealing process, and intended defect location. If a target defect is described by an opening dimension, it may be recorded in micrometers, such as 50 µm, but this number should be treated as a design input to be confirmed through method correlation rather than as a universal pass or fail limit.
The next decision is the measurement principle. Common CCI approaches include vacuum decay, pressure decay, mass extraction, tracer-gas detection, high-voltage methods, dye ingress, microbial ingress, and visual or liquid-based techniques. Each method detects a physical or chemical response, so a positive control must produce a measurable response within the equipment’s operating range.
For pressure- or vacuum-based systems, I consider the control’s internal volume, defect pathway, package flexibility, and test pressure. A sample that collapses or deforms substantially may create a response unrelated to the intended leak. For tracer-gas systems, the control should support stable tracer movement and should be evaluated under the instrument’s defined gas concentration and test cycle.
Two instruments may use the same broad test principle but apply different pressure levels, cycle times, algorithms, or acceptance criteria. A control that produces a clear response on one system may require adjustment on another. I recommend confirming the instrument model, test recipe, pressure or vacuum setting, and expected signal before finalizing the sample specification.
With competitive price and timely delivery, Zholion sincerely hope to be your supplier and partner.
For example, a project may define a test condition of 10 kPa as part of its internal method. That value is an example of a method parameter, not a generally applicable CCI requirement. The positive control should be characterized under the actual laboratory method, and the final acceptance decision should remain under the laboratory’s approved procedure.
A useful positive control has a defect that is intentional, identifiable, and relevant to the failure mode being studied. Important characteristics include defect location, approximate size or leak rate, shape, orientation, and whether the defect is open, restricted, intermittent, or affected by contact with the product or closure. The control documentation should explain what is known about the defect and what the laboratory should verify.
Some buyers focus only on a nominal opening size, but physical opening size does not always equal measured leak rate. Gas flow can be affected by pathway length, pressure differential, temperature, viscosity, surface tension, and package geometry. For this reason, I advise laboratories to define the control using the parameter that their test method actually measures, while retaining dimensional information where it is useful for traceability.
If the laboratory is establishing method capability, it may need more than one challenge level. A practical design can include a known positive control and a suitable negative control, followed by additional levels when the method’s operating range must be assessed. The exact number should be based on the validation protocol, risk assessment, and internal quality requirements rather than on a fixed purchasing rule.
Positive controls are part of the laboratory’s quality system, so handling requirements should be clear. I review storage temperature, protection from impact, cleaning restrictions, exposure limits, and the number of permitted uses. If a control can change after repeated cycling or physical handling, the laboratory should define an inspection and replacement process.
Storage conditions should be linked to the actual design and materials. A project may specify a controlled range such as 2–8 °C for a temperature-sensitive configuration, but this should only be used when supported by the product specification or study plan. Each sample should have a unique identification method, and the accompanying documents should allow the user to distinguish the control from ordinary test samples.
| Decision area | What I recommend confirming |
|---|---|
| Container match | Container material, size, closure, seal process, and defect location |
| Method compatibility | Instrument principle, test recipe, pressure or vacuum condition, and signal type |
| Defect definition | Leak pathway, approximate size or rate, repeatability, and intended failure mode |
| Documentation | Identification, use instructions, storage guidance, and change-control information |
| Supply planning | Sample quantity, replacement frequency, packaging, lead time, and customization needs |
One common mistake is selecting a control based only on the product name, without confirming the container and method. Another is treating a nominal defect dimension as a universal performance specification. A third is purchasing too few samples to support development, training, repeat testing, and future investigations.
I also recommend avoiding undocumented modifications. Drilling, puncturing, resealing, or otherwise altering a control after delivery can change the leak pathway and make results difficult to interpret. If the laboratory needs a different defect level or configuration, it is generally better to request a controlled specification or a new sample design.
At Zholion, I approach CCI positive control samples as a technical supply project. We can discuss the container format, closure system, test method, target defect characteristics, sample quantity, identification requirements, and documentation expected by the buyer’s quality system. Where the final performance criteria depend on the customer’s instrument or approved method, we use conservative language and recommend method-specific confirmation rather than making unsupported universal claims.
Our support can include requirement clarification, sample configuration review, packaging and labeling coordination, and supply planning for laboratory or validation use. The most efficient inquiry includes photographs or drawings of the package, the test method, the instrument information, the intended use, and any internal specifications already available. This allows us to evaluate feasibility more accurately and reduce avoidable changes after quotation.
The best CCI positive control sample is not simply the one with a known leak; it is the one that creates a relevant, controlled, and interpretable challenge for your specific packaging system and test method. I recommend starting with a written requirement covering the container, closure, instrument, test conditions, defect characteristics, storage, quantity, and documentation. Then ask the supplier to review the specification before production or formal quotation.
If you are selecting CCI positive control samples for laboratory quality control, packaging validation, or leak-test method development, you can provide these details to Zholion for a focused technical discussion. We will help you clarify the sample configuration and supply requirements while keeping the final performance evaluation aligned with your laboratory’s approved procedure.
Contact us to discuss your requirements of CCI Positive Control Samples. Our experienced sales team can help you identify the options that best suit your needs.